Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus

Carotid intima-media thickness in individuals with and without type 2 diabetes: a reproducibility study

(2010) Louise Lundby-Christensen et al.   Cardiovascular Diabetology

Osteoprotegerin Promotes Fibrous Cap Formation in Atherosclerotic Lesions of ApoE-Deficient Mice—Brief Report

(2009) Olga Ovchinnikova et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Associations of coronary artery calcification and carotid intima-media thickness with plasma concentrations of vascular calcification inhibitors in type 2 diabetic patients

(2009) Masami Ishiyama et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes

(2009) Lawrence H. Young et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Myocardial ischemia, carotid, and peripheral arterial disease and their interrelationship in type 2 diabetes patients

(2009) Mikael K. Poulsen et al.   JOURNAL OF NUCLEAR CARDIOLOGY

The capability of plasma osteoprotegerin as a predictor of cardiovascular disease: a systematic literature review

(2008) Mads Nybo et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Increased Matrix Metalloproteinase 2 Activity in the Human Internal Mammary Artery Is Associated with Ageing, Hypertension, Diabetes and Kidney Dysfunction

(2008) A.W. Chung et al.   JOURNAL OF VASCULAR RESEARCH

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE